The BRICS TimesTrump has imposed a 100 percent tariff on pharma, and its impact is clearly visible on Indian markets today. Several leading pharma companies in India have seen their stocks crash sharply.
Late Thursday night, Donald Trump announced tariffs on multiple sectors, including pharmaceuticals. The decision to impose a 100 percent tariff on pharma is now rattling Indian stock markets. Trading opened under heavy pressure, with the Sensex slipping 412.67 points to 80,747.01 and the Nifty falling 115 points to 24,776. Pharma stocks with high exposure to the US market faced massive selling.
Pharma Stocks Collapse After Trump’s Tariff Move
Following Trump’s declaration, shares of five major Indian pharma companies witnessed steep declines. Arvind Pharma dropped 1.91 percent to ₹1,076, while Lupin fell nearly 3 percent to ₹1,918.60. Sun Pharma tumbled 3.8 percent to ₹1,580, while Cipla saw a 2 percent dip. Strides Pharma Science slumped 6 percent, Natco Pharma dropped 5 percent, Biocon slipped 4 percent, Glenmark Pharma fell 3.7 percent, Divi’s Lab lost 3 percent, IPCA Lab declined 2.5 percent, and Zydus Life shed 2 percent. Mankind Pharma also slipped by 3.3 percent.
BSE Top 30 Under Pressure
Among the BSE’s top 30 stocks, Sun Pharma recorded the biggest fall of 3.8 percent. Infosys, Tech Mahindra, and Asian Paints also dropped by up to 2 percent each. Out of the top 30, only five shares managed to post gains while the rest slid.
Heavy Pressure on Key Sectors
The pharma sector witnessed the sharpest decline after the tariff announcement, tumbling 1.8 percent in early trade. The IT sector, impacted by H-1B visa concerns, slipped 1.3 percent, while healthcare stocks also plunged by 1.5 percent.
88 Stocks Hit 52-Week Lows
Out of 3,073 BSE-listed shares, 864 were trading higher while 2,062 were in the red. Trading remained flat for 147 stocks. Around 76 stocks hit the upper circuit, while 65 fell to the lower circuit. A total of 88 stocks touched their 52-week lows, indicating the depth of selling pressure across the market.
Investors Suffer Massive Losses
The fall in stock prices has triggered significant wealth erosion for investors. The market capitalization of BSE slipped to ₹454 lakh crore today from ₹457 lakh crore yesterday. This means investors collectively lost nearly ₹3 lakh crore in just a single session.
